Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
Renaissance Technologies 13.75M $102.68M Sept. 30, 2014
BlackRock Fund Advisors 11.54M $86.23M Sept. 30, 2014
Vanguard 10.33M $77.17M Sept. 30, 2014
Schroder Investment Management 8.72M $65.15M Sept. 30, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
Acadian Asset Management 6.59M $49.25M Sept. 30, 2014
FMR 6.37M $49.20M June 30, 2013
Advisors Asset Management 4.85M $36.20M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 4.56M $34.10M Sept. 30, 2014
Bank of America Corporation 4.51M $33.69M Sept. 30, 2014
Wells Fargo & Company 4.10M $39.68M June 30, 2014
STATE STREET CORPORATION 3.48M $26.00M Sept. 30, 2014
Gotham Asset Management 3.34M $28.22M Dec. 31, 2013
AQR Capital Management 2.98M $22.97M June 30, 2013
MSDC Management 2.86M $18.94M June 30, 2012
OppenheimerFunds 2.82M $18.71M June 30, 2012
Two Sigma Advisers 2.80M $21.52M Sept. 30, 2012
DIMENSIONAL FUND ADVISORS 2.72M $20.29M Sept. 30, 2014
NORTHERN TRUST 2.69M $20.01M Sept. 30, 2014
Inves 2.56M $19.12M Sept. 30, 2014
Two Sigma Investments 2.47M $17.44M Dec. 31, 2012
NUMERIC INVESTORS 2.42M $20.40M Dec. 31, 2013
MORGAN STANLEY 2.41M $18.02M Sept. 30, 2014
ARONSON JOHNSON ORTIZ 2.36M $17.26M March 31, 2013
Royal Bank of Canada 2.28M $22.11M June 30, 2014
Hussman Econometrics Advisors 2.22M $17.68M Sept. 30, 2013

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Paulson & Co March 31, 2008 5.40M $57.16M